CD4 and rheumatoid arthritis: Hence, significantly (P = 2 × 10−9) more of the CpG sites were differentially methylated in CD4+ memory T cells (0.5%) than in CD4+ naïve T cells (0.02%) from the newly diagnosed DMARD naïve RA patients.